Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Marinus Pharmaceuticals (MRNS)

Marinus Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MRNS
DateTimeSourceHeadlineSymbolCompany
02/01/202520:25Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:MRNSMarinus Pharmaceuticals Inc
02/01/202520:25Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:MRNSMarinus Pharmaceuticals Inc
30/12/202412:11Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:MRNSMarinus Pharmaceuticals Inc
30/12/202412:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
30/12/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
30/12/202412:00Business WireImmedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.NASDAQ:MRNSMarinus Pharmaceuticals Inc
23/12/202421:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
10/12/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
10/12/202420:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRNSMarinus Pharmaceuticals Inc
15/11/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
14/11/202423:39Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
14/11/202420:04Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
14/11/202417:24Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
14/11/202414:34Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRNSMarinus Pharmaceuticals Inc
12/11/202421:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRNSMarinus Pharmaceuticals Inc
12/11/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
12/11/202421:00Business WireMarinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:MRNSMarinus Pharmaceuticals Inc
02/11/202400:30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
02/11/202400:30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
02/11/202400:30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:MRNSMarinus Pharmaceuticals Inc
24/10/202412:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
24/10/202412:00Business WireMarinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic AlternativesNASDAQ:MRNSMarinus Pharmaceuticals Inc
17/10/202411:00Business WireMarinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual MeetingNASDAQ:MRNSMarinus Pharmaceuticals Inc
15/10/202420:00Business WireMarinus Pharmaceuticals Further Strengthens Intellectual Property Estate with Method of Treatment Patent for ZTALMY® Titration RegimensNASDAQ:MRNSMarinus Pharmaceuticals Inc
09/10/202411:00Business WireMarinus Pharmaceuticals Announces Podium and Poster Presentations at the Neurocritical Care Society 2024 Annual MeetingNASDAQ:MRNSMarinus Pharmaceuticals Inc
08/10/202420:04Business WireMarinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:MRNSMarinus Pharmaceuticals Inc
02/10/202411:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
20/09/202412:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNSMarinus Pharmaceuticals Inc
20/09/202412:00Business WireMarinus Pharmaceuticals to Highlight Clinical Progress and Commercial Launch Preparedness for ZTALMY® in TSC at Investor and Analyst DayNASDAQ:MRNSMarinus Pharmaceuticals Inc
12/09/202412:00Business WireMarinus Pharmaceuticals Announces Agenda and Speakers for Investor & Analyst Day on September 20, 2024NASDAQ:MRNSMarinus Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:MRNS